Literature DB >> 35497585

Microwave-assisted simple synthesis of 2-anilinopyrimidines by the reaction of 2-chloro-4,6-dimethylpyrimidine with aniline derivatives.

Cristina Campestre1, György Keglevich2, János Kóti3, Luca Scotti4, Carla Gasbarri1, Guido Angelini1.   

Abstract

A series of 2-anilinopyrimidines including novel derivatives has been obtained from 2-chloro-4,6-dimethylpyrimidine by aromatic nucleophilic substitution with differently substituted anilines under microwave conditions. The substituents had a significant impact on the course and efficiency of the reaction. The results reported herein demonstrate the efficacy of microwaves in the synthesis of the title heterocyclic compounds as compared to the results obtained with conventional heating. The 2-anilinopyrimidines described are of potential bioactivity. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2020        PMID: 35497585      PMCID: PMC9050660          DOI: 10.1039/d0ra00833h

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


Introduction

The biological activity of anilinopyrimidines as fungicides and pesticides is well-known and widely reported.[1-7] Recently, a few 2-anilinopyrimidine derivatives have been evaluated as kinase inhibitors having antiproliferative activity against cancer cell lines.[8-11] The role of this class of compounds in the generation of supramolecular networks for molecular recognition has also been demonstrated.[12] Different methods have been proposed to synthesize anilinopyrimidines: (a) the cyclization between guanidines (generally obtained from isothiourea salts and alkyl(aryl)amines in the presence of strong bases) and β-diketones, ethyl acetoacetate or ethyl cyanoacetate under refluxing for several hours (b) the transition metal-free cross-coupling reactions, (c) the aromatic nucleophilic substitution of halogen pyrimidines or substituted heterocycles having an alkylsulfonyl group with anilines.[13-16] In particular, the substitution of the halogen atom in 2-aminopyrimidines by alkyl- or arylamines occurs under acidic conditions.[17,18] The main disadvantage of these procedures is the requirement for drastic conditions and long reaction times. In the last years a large number of heterocyclic compounds including anilinopyrimidines has been synthesized by microwave (MW) irradiation.[19-21] The main advantage of the use of this technique is the decrease of the reaction time from several hours to a few minutes or seconds in comparison to the results obtained on conventional heating.[22,23] Moreover, less by-products are formed in MW-assisted reactions.[24] However, in most cases, it is not possible to predict if a given reaction will be improved under MWs or not.[25] At the same time, if the energetics of the target reaction is known, it is possible to judge in advance about the appropriateness of the application of MWs. The ideal subject of MW-promoted reactions are those that have a relatively high enthalpy of activation, and are thermoneutral.[26-28] In this article we describe the simple synthesis of a series of anilinopyrimidine derivatives including three new compounds by the reaction of 2-chloro-4,6-dimethylpyrimidine with substituted anilines under MW irradiation. This method represents a novel approach to the synthesis of the target compounds, and allows high yields in eco-friendly conditions. Recently, some green and recyclable reaction media have been proposed, such as water, PEG-200, and 2-methyltetrahydrofuran.[29-31] The use of ethanol, one of the environmentally preferable solvents, confers the eco-friendly character to the synthesis of the investigated compounds.[32-34]

Results and discussion

Recently, it has been demonstrated that acid catalysis promoted the reaction of chloro-N-heterocycles with anilines.[19,35] The reaction between 2-chloro-4,6-dimethylpyrimidine and substituted anilines in ethanol at 160 °C under MW irradiation for 10 min, is an aromatic nucleophilic substitution taking place via the corresponding Meisenheimer complexes, and affording 2-anilinopyrimidines. An aminopyrimidine from benzylamine has also been synthesized as shown in Scheme 1.
Scheme 1

MW-assisted synthesis of the compounds (1–17).

Yields of the 2-anilinopyrimidine derivatives (1–16) and benzylaminopyrimidine (17) are listed in Table 1. All the target compounds were prepared with high yields (71–99%) except compound (10). Pure products were obtained after column chromatography, and their structure was confirmed by 1H and 13C-NMR as well as mass spectral data.

Preparative data and melting points for the synthesized products (1–17)

CompoundXYZW n Yield/%mp (lit)/°C
1OCH3OCH3OCH3H090167.5–169
2HHHH09196–98 (96–97)[21]
3HOCH3HH09090–92 (88–89)[21]
4HOHHH092170–172 (170–172)[36]
5HCH3HH099116–117 (107–108)[36]
6HBrHH098123–124 (123–124)[36]
7HClHH082118–120 (153)[36]
8HFHH07191–93 (91–93)[36]
9HCF3HH087106.5–108
10HNO2HH039221–223 (230)[36]
11HC6H5HH091114–115.5
12HN <svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata> Created by potrace 1.16, written by Peter Selinger 2001-2019 </metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg> N–C6H5HH091159.5–161
13CH2OHHHH097106–108
14FHHH097132–134 (132–134)[36]
15OHHHH085137.5–139 (157)[36]
16HHHCH3090111–112 (92–93)[36]
17HHHH195109–111 (111–112)[21]
The bis-derivative (18) was obtained according to Scheme 2, under the same conditions as compounds (1–17), starting from 2-chloro-4,6-dimethylpyrimidine and 4,4′-dithiobis(benzenamine).
Scheme 2

MW-assisted synthesis of bis-derivative (18).

In order to verify the role of MWs in the investigated reactions, compound (1) was also synthesized on conventional heating at reflux for 72 h. After the work-up described in the general procedure, product (1) was isolated in a yield of 68% that is significantly lower than that obtained by MW irradiation (90%). It has been demonstrated that in the MW-assisted synthesis, the polarity and polarizability of the reagents, transition states and intermediates may influence the absorption of MWs and hence the heating.[37] The presence of substituents, their electronic effects and their position in the aromatic ring may influence the properties of the compounds, and the rate of their reactions.[38-43] In the investigated SNAr reactions, the electron-donating effect (+I) of the alkyl group increases the nucleophilic nature of the amino group of the aniline moiety, as it was demonstrated by the high yields obtained for compounds (5) and (16) due to the presence of the CH3 group in the para or ortho position, respectively (Table 1). A similar effect was observed in the phenyl substituted instance (11). In case of products (3) and (4), the high yields of 90 and 92%, respectively, are the consequence of the electron-releasing MeO and HO groups. These substituents can promote the reactivity of the aniline molecule because of the major +M effect versus the −I effect. On the other hand, regarding compound (10), in which the nitro group posseses an −M effect, nucleophilicity of the amino group is decreased, as it was demonstrated by the lower yield of 39%. Compounds (1), (2) and (3) are well-known molecules: heterocycle (1) has been recently patented for its antimitotic activity as a topical formulation against psoriasis,[44] while derivatives (2) and (3) are commercial fungicides pyrimethanil and andoprim, respectively.[2,45,46] In this work, these species and their analogues have been synthesized in a one pot reaction instead of the guanidine route.[14] To the best of our knowledge, compounds (11), (12) and (18) are reported for the first time.

Conclusions

MW irradiation allowed rapid and high yield “green” synthesis of a series of 2-anilinopyrimidines. In this work, 18 products were prepared, including new compounds (11), (12) and (18) and the benzylamine derivative (17). The electronic effect of the substituents had an impact on the outcome of the reaction by influencing the nucleophilic character of the amino group of the aniline molecule. As N-heterocycle-based molecules are important due to their applicability in medicinal chemistry,[47] the compounds synthesized beyond the antimitotic (1) and fungicidal (2) and (3) may also posses bioactive properties.

Experimental

Material and methods

All the reagents, were purchased from commercial suppliers and employed without further purification. Reactions were monitored by thin layer chromatography (TLC) on silica gel plates (60 F254) that were visualized under UV light (254 nm). The silica gel (Kieselgel 4°, 0.04–0.063 mm) used in the column chromatography was purchased from Merck. The MW-assisted reactions were performed using a Biotage Initiator Plus oven. Infrared absorption spectra were recorded on a Varian 1000 Fourier-transform infrared spectrometer. The 1H and 13C-NMR spectra were recorded on a Varian-Mercury 300 spectrometer, operating at a frequency of 300 MHz and 75 MHz, respectively. Melting points were determined on a Büchi B-540 apparatus and are uncorrected. Electrospray high-resolution MS measurements were performed on a Thermo Velos Pro Orbitrap Elite Hybrid Mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). The ionization method was ESI and operated in positive ion mode. The capillary temperature was set at 275 °C. Samples were infused into the ESI source MeOH solutions at a flow rate of 3 μL min−1. Resolving power of 60 000 (FWHM) at m/z 400. Data acquisition and analysis were accomplished with Xcalibur software version 3.0 (Thermo Fisher Scientific Inc.).

General procedure for the synthesis of compounds (1–17)

The appropriate aniline (1.0 mmol), 2-chloro-4,6-dimethylpyrimidine (114 mg, 0.80 mmol), and ethanol (4 mL) were placed in a 5 mL reaction vial, sealed and irradiated at 160 °C for 10 min under magnetic stirring. The solid residue was taken up in 30 mL of CH2Cl2, and the solution washed with 0.25 M Na2CO3 (2 × 20 mL) and dried over Na2SO4. The solvent was evaporated, and the crude product so obtained purified by silica gel column chromatography. The yields were calculated combining the fractions having only one spot on TLC. According to the NMR spectra, purity of the compounds is ≥ 99%. The following products were thus prepared:

4,6-Dimethyl-N-(3,4,5-trimethoxyphenyl)-2-pyrimidinamine (1)

Yield = 90%; white solid; mp 167.5–169 °C. It was obtained from 183 mg of 3,4,5-trimethoxyaniline and purified by column chromatography starting from hexane to hexane–ethyl acetate (8 : 2) as the eluent. IR (KBr) νmax cm−1 3317, 2951, 1612, 1593, 1544; 1H-NMR (CDCl3): δ 2.37 (s, 6H, 2CH3), 3.80 (s, 3H, OCH3), 3.85 (s, 6H, 2 OCH3), 6.49 (s, 1H, Ar Pyr), 6.99 (s, 2H, Ar), 7.32 (s, 1H, NH); 13C-NMR (CDCl3): δ 23.9, 56.0, 61.1, 96.8, 111.6, 135.9, 153.3, 159.3, 167.6; ESI-HRMS [M + H]+ found = 290.14950, C15H20N3O3 requires = 290.14992.

4,6-Dimethyl-N-phenyl-2-pyrimidinamine (2)

Yield = 91%; yellow solid; mp 96–98 °C. It was obtained from 93 mg of aniline and purified by column chromatography starting from hexane to hexane–ethyl acetate (8 : 2) as the eluent. IR (KBr) νmax cm−1 3260, 2967, 1614, 1589, 1566, 1548; 1H-NMR (CDCl3): δ 2.37 (s, 6H, 2CH3), 6.48 (s, 1H, Ar Pyr), 6.98–7.03 (m, 1H, Ar), 7.29–7.34 (m, 2H, Ar), 7.43 (s, 1H, NH), 7.66–7.69 (m, 2H, Ar); 13C-NMR (CDCl3): δ 23.9, 111.7, 118.9, 122.1, 128.9, 139.9, 159.7, 167.6; ESI-HRMS [M + H]+ found = 200.11781, C12H14N3 requires = 200.11822.

N-(4-Methoxylphenyl)-4,6-dimethyl-2-pyrimidinamine (3)

Yield = 90%; brown solid; mp 90–92 °C. It was obtained from 123 mg of 4-anisidine and purified by column chromatography starting from hexane to hexane–ethyl acetate (8 : 2) as the eluent. IR (KBr) νmax cm−1 3266, 2960, 1602, 1583, 1563, 1545; 1H-NMR (CDCl3): δ 2.33 (s, 6H, 2CH3), 3.78 (s, 3H, OCH3), 6.43 (s, 1H, Ar Pyr), 6.86 (d, J = 8.7, 2H, Ar), 7.34 (s, 1H, NH), 7.53 (d, J = 8.7, 2H, Ar); 13C-NMR (CDCl3): δ 23.9, 55.6, 111.2, 114.2, 121.1, 133.1, 155.2, 159.9, 167.6; ESI-HRMS [M + H]+ found = 230.12824, C13H16N3O requires = 230.12879.

4-[(4,6-Dimethylpyrimidine-2-yl)-amino]-phenol (4)

Yield = 92%; brown solid; mp 170–172 °C. It was obtained from 109 mg of 4-aminophenol and purified by column chromatography starting from hexane to and hexane–ethyl acetate (6 : 4) as the eluent. IR (KBr) νmax cm−1 3217, 2958, 1598, 1585, 1561, 1546; 1H-NMR (CD3OD): δ 2.27 (s, 6H, 2CH3), 4.88 (s, 1H, NH) (s, 1H, OH), 6.47 (s, 1H, Ar Pyr), 6.73 (d, J = 8.9, 2H, Ar), 7.39 (d, J = 8.9, 2H, Ar), 13C-NMR (CD3OD): δ 26.3, 114.1, 118.7, 125.8, 135.9, 156.6, 164.3, 171.65; ESI-HRMS [M + H]+ found = 216.11271, C12H14N3O requires = 216.11314.

4,6-Dimethyl-N-(4-methylphenyl)-2-pyrimidinamine (5)

Yield = 99%; brown solid; mp 116–117 °C. It was obtained from 107 mg of 4-toluidine and purified by column chromatography starting from hexane to hexane–ethyl acetate (9 : 1) as the eluent. IR (KBr) νmax cm−1 3263, 2964, 1609, 1585, 1565, 1541; 1H-NMR (CDCl3): δ 2.31 (s, 3H, CH3), 2.35 (s, 6H, 2CH3), 6.45 (s, 1H, Ar Pyr), 7.12 (d, J = 8.1, 2H, Ar), 7.43 (s, 1H, NH), 7.54 (d, J = 8.1, 2H, Ar); 13C-NMR (CDCl3): δ 20.8, 23.9, 111.3, 119.2, 129.4, 131.6, 137.3, 159.8, 167.6; ESI-HRMS [M + H]+ found = 214.13349, C13H16N3 requires = 214.13387.

N-(4-Bromophenyl)-4,6-dimethyl-2-pyrimidinamine (6)

Yield = 98%; white solid; mp 123–124 °C. It was obtained from 172 mg of 4-bromoaniline and purified by column chromatography starting from CH2Cl2 to CH2Cl2–isopropanol (95 : 5) as the eluent. IR (KBr) νmax cm−1 3408, 2962, 1595, 1564, 1519; 1H-NMR (CDCl3): δ 2.33 (s, 6H, 2CH3), 6.47 (s, 1H, Ar Pyr), 7.36 (d, J = 8.7, 2H, Ar), 7.54 (d, J = 8.7, 2H, Ar), 7.67 (s, 1H, NH); 13C-NMR (CDCl3): δ 23.9, 111.9, 114.1, 120.4, 131.6, 139.1, 159.4, 167.6; ESI-HRMS [M + H]+ found = 278.02861, C12H13BrN3 requires = 278.02874.

N-(4-Chlorophenyl)-4,6-dimethyl-2-pyrimidinamine (7)

Yield = 82%; brown solid; mp 118–120 °C. It was obtained from 128 mg of 4-chloroaniline and purified by column chromatography starting from CH2Cl2 to CH2Cl2–isopropanol (98 : 2) as the eluent. IR (KBr) νmax cm−1 3317, 2949, 1612, 1593, 1544,; 1H-NMR (acetone d6): δ 2.31 (s, 6H, 2CH3), 6.59 (s, 1H, Ar Pyr), 7.29 (d, J = 8.8, 2H, Ar), 7.95 (d, J = 8.8, 2H, Ar), 8.59 (s, 1H, NH); 13C-NMR (acetone d6): δ 23.9, 112.2, 120.9, 126.1, 129.1, 140.9, 160.7, 168.2; ESI-HRMS [M + H]+ found = 234.07884, C12H13ClN3 requires = 234.07925.

N-(4-Fluorophenyl)-4,6-dimethyl-2-pyrimidinamine (8)

Yield = 71%; brown solid; mp 91–93 °C. It was obtained from 111 mg of 4-fluoroaniline and purified by column chromatography starting from CH2Cl2 to CH2Cl2–isopropanol (98 : 2) as the eluent. IR (KBr) νmax cm−1 3267, 2964, 1614, 1595, 1566, 1550; 1H-NMR (CDCl3): δ 2.34 (s, 6H, 2CH3), 6.47 (s, 1H, Ar Pyr), 6.95–7.01 (m, 2H, Ar), 7.48 (s, 1H, NH), 7.56–7.60 (m, 2H, Ar); 13C-NMR (CDCl3): δ 23.8, 111.6, 115.3 (d, J = 22), 120.6 (d, J = 6.7), 135.8, 158.3 (d, J = 242), 159.4, 167.6; ESI-HRMS [M + H]+ found = 218.10849, C12H13FN3 requires = 218.10880.

4,6-Dimethyl-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine (9)

Yield = 87%; yellow solid; mp 106.5–108 °C. It was obtained from 161 mg of 4-trifluoromethylaniline and purified by column chromatography using hexane–ethyl acetate (9 : 1) as the eluent. IR (KBr) νmax cm-1 3435, 2989, 1618, 1600, 1598, 1535; 1H-NMR (CDCl3): δ 2.39 (s, 6H, 2CH3), 6.55 (s, 1H, Ar Pyr), 7.53 (d, J = 8.4, 2H, Ar), 7.73 (s, 1H, NH), 7.78 (d, J = 8.4, 2H, Ar); 13C-NMR (CDCl3): δ 23.9, 112.5, 118.1, 122.5, 126.1, 143.1, 159.2, 167.8; ESI-HRMS [M + H]+ found = 268.10489, C13H13F3N3 requires = 268.10561.

4,6-Dimethyl-N-(4-nitrophenyl)-2-pyrimidinamine (10)

Yield = 39%; yellow solid; mp 221–223 °C. It was obtained from 138 mg of 4-nitroaniline and purified by column chromatography starting from hexane to hexane–ethyl acetate (8 : 2) as the eluent. IR (KBr) νmax cm−1 3383, 2985, 1600, 1564, 1541, 1506; 1H-NMR (CDCl3): δ 2.49 (s, 6H, 2CH3), 6.68 (s, 1H, Ar Pyr), 7.86 (d, J = 8.7, 2H, Ar), 8.21 (d, J = 8.7, 2H, Ar), 8.70 (s, 1H, NH); 13C-NMR (CDCl3): δ 23.7, 113.3, 118.5, 125.4, 142.4, 144.9, 156.9, 168.1; ESI-HRMS [M + H]+ found = 245.10289, C12H13N4O2 requires = 245.10330.

N-(Biphenyl-4-yl)-4,6-dimethyl-2-pyrimidinamine (11)

Yield = 91%; light brown solid; mp 114–115.5 °C. It was obtained from 169 mg of 4-aminobiphenyl and purified by column chromatography starting from CH2Cl2–hexane (2 : 8), to CH2Cl2 as the eluent. IR (KBr) νmax cm−1 3242, 2962, 1602, 1573, 1561, 1534; 1H-NMR (CDCl3): δ 2.41 (s, 6H, 2CH3), 6.50 (s, 1H, Ar Pyr), 7.31–7.36 (m, 1H, Ar), 7.43–7.48 (m, 2H, Ar), 7.58–7.64 (m, 4H, Ar, s, 1H, NH), 7.78–7.82 (m, 2H, Ar), 13C-NMR (CDCl3): δ 23.9, 111.7, 119.2, 126.7, 127.5, 128.8, 134.8, 139.4, 140.9, 159.6, 167.6; ESI-HRMS [M + H]+ found = 276.14892, C18H18N3 requires = 276.14952.

4,6-Dimethyl-N-{4-[(E)-phenyldiazenyl]-phenyl}-2-pyrimidinamine (12)

Yield = 91%; red solid; mp 159.5–161 °C. It was obtained from 197 mg of 4-aminobenzene and purified by column chromatography using hexane–ethyl acetate (9 : 1) as the eluent. IR (KBr) νmax cm−1 3278, 2960, 1604, 1585, 1562, 1535; 1H-NMR (CDCl3): δ 2.39 (s, 6H, 2CH3), 6.52 (s, 1H, Ar Pyr), 7.39–7.52 (m, 3H, Ar), 7.83–7.96 (m, 7H, Ar, NH); 13C-NMR (CDCl3): δ 23.9, 112.5, 118.5, 122.6, 124.2, 129.1, 130.3, 142.9, 147.5, 152.9, 159.1, 167.7; ESI-HRMS [M + H]+ found = 304.15492, C18H18N5 requires = 304.15567.

{3-[(4,6-Dimethylpyrimidine-2-yl)-amino]-phenyl}-methanol (13)

Yield = 97%; yellow solid; mp 106–108 °C. It was obtained from 123 mg of 3-aminobenzyl alcohol and purified by column chromatography starting from hexane to hexane–ethyl acetate (1 : 1) as the eluent. IR (KBr) νmax cm−1 3271, 2939, 1618, 1593, 1556, 1548; 1H-NMR (CDCl3): δ 2.32 (s, 6H, 2CH3), 3.73 (bs, 1H, OH), 4.62 (s, 2H, CH2), 6.43 (s, 1H, Ar Pyr), 6.93–6.95 (m, 1H, Ar), 7.19–7.25 (m, 1H, Ar), 7.37 (s, 1H, NH), 7.49 (bs, 1H, Ar), 7.58–7.61 (m, 1H, Ar); 13C-NMR (CDCl3): δ 23.8, 64.8, 111.6, 117.5, 118.1, 120.7, 128.9, 139.9, 141.9, 159.4, 167.6; ESI-HRMS [M + H]+ found = 230.12849, C13H16N3O requires = 230.12879.

N-(3-Fluorophenyl)-4,6-dimethyl-2-pyrimidinamine (14)

Yield = 97%; white solid; mp 132–134 °C. It was obtained from 111 mg of 3-fluoroaniline and purified by column chromatography starting from CH2Cl2 to CH2Cl2–isopropanol (95 : 5) as the eluent. IR (KBr) νmax cm−1 3419, 2922, 1602, 1587, 1566, 1539; 1H-NMR (CDCl3): δ 2.37 (s, 6H, 2CH3), 6.51 (s, 1H, Ar Pyr), 6.63–6.71 (m, 1H, Ar), 7.12–7.24 (m, 2H, Ar), 7.62 (s, 1H, NH), 7.78–7.83 (m, 1H, Ar); 13C-NMR (CDCl3): δ 23.9, 105.9 (d, J = 27.0), 108.5 (d, J = 22), 112.2, 114.1 (d, J = 2.5), 129.8 (d, J = 9.9), 141.7 (d, J = 5.8), 159.4, 163.3 (d, J = 242), 167.7; ESI-HRMS [M + H]+ found = 218.10851, C12H13FN3 requires = 218.10880.

3-[(4,6-Dimethylpyrimidine-2-yl)-amino]-phenol (15)

Yield = 85%; brown solid; mp 137.5–139 °C. It was obtained from 109 mg of 3-aminophenol and purified by column chromatography starting from CH2Cl2–isopropanol (99 : 1) to CH2Cl2–isopropanol (8 : 2) as the eluent. IR (KBr) νmax cm−1 3365, 2995, 1620, 1610, 1589, 1568, 1548; 1H-NMR (acetone d6): δ 2.30 (s, 6H, 2CH3), 6.45–6.48 (m, 1H, Ar), 6.54 (s, 1H, Ar Pyr), 7.05–7.11 (m, 1H, Ar), 7.26–7.30 (m, 1H, Ar), 7.66–7.68 (m, 1H, Ar), 8.37 (s, 1H, NH); 13C-NMR (acetone d6): δ 23.8, 106.6, 109.1, 110.8, 111.7, 129.9, 142.9, 158.5, 160.8, 168.1; ESI-HRMS [M + H]+ found = 216.11285, C12H14N3O requires = 216.11314.

4,6-Dimethyl-N-(2-methylphenyl)-2-pyrimidinamine (16)

Yield = 90%; red solid; mp 111–112 °C. It was obtained from 107 mg of 4-toluidine and purified by column chromatography starting from hexane to hexane–ethyl acetate (8 : 2) as the eluent. IR (KBr) νmax cm−1 3218, 2964, 1600, 1568, 1555; 1H-NMR (CDCl3): δ 2.32 (s, 3H, CH3), 2.36 (s, 6H, 2CH3), 6.48 (s, 1H, Ar Pyr), 6.87 (s, 1H, 1N), 6.96–7.01 (m, 1H, Ar), 7.17–7.25 (m, 2H, Ar), 8.17–8.19 (m, 1H, Ar); 13C-NMR (CDCl3): δ 18.3, 24.0, 111.7, 120.9, 122.9, 126.6, 127.7, 130.5, 137.9, 160.1, 167.7; ESI-HRMS [M + H]+ found = 214.13352, C13H16N3 requires = 214.13387.

4,6-Dimethyl-N-(2-benzylamino)-2-pyrimidinamine (17)

Yield = 95%; white solid; mp 109–111 °C. It was obtained from 107 mg of benzylamine and purified by column chromatography starting from hexane to hexane–ethyl acetate (8 : 2) as the eluent. IR (KBr) νmax cm−1 3254, 2964, 1600, 1583, 1570, 1559; 1H-NMR (CDCl3): δ 2.26 (s, 3H, CH3), 4.66 (d, J = 5.7, 2H), 5.85 (s, 1H), 6.29 (s, 1H, Ar Pyr), 7.22–7.36 (m, 5H, Ar); 13C-NMR (CDCl3): δ 24.0, 45.3, 109.9, 127.0, 127.5, 128.5, 139.7, 162.2, 167.5; ESI-HRMS [M + H]+ found = 214.13349, C13H16N3 requires = 214.13387.

Procedure for the synthesis of compound (18)

N,N'-[Dithiobis(4,1-phenylene)]bis(4,6-dimethylpyrimidin-2-amine) (18)

Yield = 90%; yellow solid; mp 169.5–170.5 °C. It was obtained from 124 mg of 4,4′-dithiobis(benzenamine) and 142 mg of 2-chloro-4,6-dimethylpyrimidine and purified by column chromatography using hexane–ethyl acetate (3 : 2) as the eluent. IR (KBr) νmax cm−1 3259, 2962, 1610, 1580, 1568, 1563, 1553; 1H-NMR (CDCl3): δ 2.35 (s, 6H, CH3), 6.48 (s, 1H, Ar Pyr), 7.42 (d, J = 8.6, 2H, Ar), 7.61 (d, J = 8.6, 2H, Ar), 7.76 (s, 1H, 1N); 13C-NMR (CDCl3): δ 23.9, 112.0, 119.2, 129.6, 131.2, 140.1, 159.3, 167.6; ESI-HRMS [M + H]+ found = 461.15649, C24H25N6S2 requires = 461.15766.

Conflicts of interest

There are no conflict to declare.
  22 in total

Review 1.  A Critical Overview on the Effect of Microwave Irradiation in Organic Synthesis.

Authors:  Á Díaz-Ortiz; P Prieto; A de la Hoz
Journal:  Chem Rec       Date:  2018-07-23       Impact factor: 6.771

2.  Discovery and SAR studies of novel 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cell line MDA-MB-468.

Authors:  Jeyun Jo; Sou Hyun Kim; Heegyu Kim; Myeonggyo Jeong; Jae-Hwan Kwak; Young Taek Han; Jee-Yeong Jeong; Young-Suk Jung; Hwayoung Yun
Journal:  Bioorg Med Chem Lett       Date:  2018-11-08       Impact factor: 2.823

3.  Insights into a surprising reaction: the microwave-assisted direct esterification of phosphinic acids.

Authors:  György Keglevich; Nóra Zsuzsa Kiss; Zoltán Mucsi; Tamás Körtvélyesi
Journal:  Org Biomol Chem       Date:  2012-02-01       Impact factor: 3.876

4.  Role of Solvent and Effect of Substituent on Azobenzene Isomerization by Using Room-Temperature Ionic Liquids as Reaction Media.

Authors:  Guido Angelini; Nadia Canilho; Mélanie Emo; Molly Kingsley; Carla Gasbarri
Journal:  J Org Chem       Date:  2015-07-09       Impact factor: 4.354

5.  Evaluation of anilinopyrimidine and other fungicides for control of grey mould (Botrytis cinerea) in container-grown Calluna vulgaris.

Authors:  Mark P McQuilken; J Thomson
Journal:  Pest Manag Sci       Date:  2008-07       Impact factor: 4.845

6.  Effects of fludioxonil and pyrimethanil, two fungicides used against Botrytis cinerea, on carbohydrate physiology in Vitis vinifera L.

Authors:  Gaëlle Saladin; Christian Magné; Christophe Clément
Journal:  Pest Manag Sci       Date:  2003-10       Impact factor: 4.845

7.  Hydrogen bond contribution to preferential solvation in S(N)Ar reactions.

Authors:  Rodrigo Ormazabal-Toledo; José G Santos; Paulina Ríos; Enrique A Castro; Paola R Campodónico; Renato Contreras
Journal:  J Phys Chem B       Date:  2013-05-02       Impact factor: 2.991

8.  Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase.

Authors:  John G Cumming; Caroline L McKenzie; Stuart G Bowden; Douglas Campbell; David J Masters; Jason Breed; Philip J Jewsbury
Journal:  Bioorg Med Chem Lett       Date:  2004-11-01       Impact factor: 2.823

9.  2-Anilino-4-(benzimidazol-2-yl)pyrimidines--a multikinase inhibitor scaffold with antiproliferative activity toward cancer cell lines.

Authors:  Renate Determann; Jan Dreher; Knut Baumann; Lutz Preu; Peter G Jones; Frank Totzke; Christoph Schächtele; Michael H G Kubbutat; Conrad Kunick
Journal:  Eur J Med Chem       Date:  2012-04-14       Impact factor: 6.514

10.  Activation of Electrophile/Nucleophile Pair by a Nucleophilic and Electrophilic Solvation in a SNAr Reaction.

Authors:  Bruno Sánchez; Cristian Calderón; Ricardo A Tapia; Renato Contreras; Paola R Campodónico
Journal:  Front Chem       Date:  2018-10-23       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.